Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2020

Publisher Name :
Date: 30-Apr-2020
No. of pages: 278
Inquire Before Buying

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2020

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Toxicity - Pipeline Review, H1 2020, provides an overview of the Radiation Toxicity (Toxicology) pipeline landscape.

Radiation Toxicity (also known as radiation sickness) is an acute illness caused by irradiation of the entire body by a high dose of penetrating radiation in a very short period of time (usually a matter of minutes). The major cause of this syndrome is depletion of immature parenchymal stem cells in specific tissues. Symptoms include bleeding from the nose, mouth, gums, and rectum, bloody stool, bruising, confusion, dehydration, diarrhea, fainting and fatigue.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Radiation Toxicity - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Radiation Toxicity (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Radiation Toxicity (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 4, 7, 8, 1, 44, 7 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 6 and 1 molecules, respectively.

Radiation Toxicity (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Radiation Toxicity (Toxicology).

- The pipeline guide reviews pipeline therapeutics for Radiation Toxicity (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Radiation Toxicity (Toxicology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Radiation Toxicity (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Radiation Toxicity (Toxicology)

Reasons to Buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Radiation Toxicity (Toxicology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Radiation Toxicity (Toxicology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2020

Table of Contents
Introduction
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Overview
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Therapeutics Development
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Therapeutics Assessment
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Companies Involved in Therapeutics Development
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Drug Profiles
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Dormant Projects
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Discontinued Products
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Products under Development by Companies, H1 2020 (Contd..4), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by 21st Century Therapeutics Inc, H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Advanced Innovative Partners Inc, H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Advenchen Laboratories LLC, H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Amryt Pharma Plc, H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Angion Biomedica Corp, H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Atox Bio Ltd, H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by BCN Biosciences LLC, H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Dormant Projects, H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Dormant Projects, H1 2020 (Contd..1), H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Dormant Projects, H1 2020 (Contd..2), H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Dormant Projects, H1 2020 (Contd..3), H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Dormant Projects, H1 2020 (Contd..4), H1 2020
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020
  • Global Medical Cannabis Oil Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Medical Cannabis Oil market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Cannabis Oil business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Cannabis Oil market by ......
  • Global Medical Use Empty Capsules Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 161
    According to this study, over the next five years the Medical Use Empty Capsules market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Use Empty Capsules business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Use Empty C......
  • Global Systemic Lupus Erythematosus (SLE) Medication Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 133
    According to this study, over the next five years the Systemic Lupus Erythematosus (SLE) Medication market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Systemic Lupus Erythematosus (SLE) Medication business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growt......
  • Global Pets Vitamins and Supplements Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Pets Vitamins and Supplements market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pets Vitamins and Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Pets Vitamins......
  • Global Soft Elastic Capsule Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Soft Elastic Capsule market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Soft Elastic Capsule business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Soft Elastic Capsule market by ......
  • Global Anti-worm Medication Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 162
    According to this study, over the next five years the Anti-worm Medication market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anti-worm Medication business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-worm Medication market by ......
  • Global Albendazole Anthelmintic Drug Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Albendazole Anthelmintic Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Albendazole Anthelmintic Drug business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Albendazole A......
  • Global Immune System Supplements Market Growth (Status and Outlook) 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 138
    According to this study, over the next five years the Immune System Supplements market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Immune System Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Immune System Supplements market......
  • Global Antipyretic Analgesics Market Growth (Status and Outlook) 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Antipyretic Analgesics market will register a 1.3%% CAGR in terms of revenue, the global market size will reach $ 2693.6 million by 2025, from $ 2561.5 million in 2019. In particular, this report presents the global revenue market share of key companies in Antipyretic Analgesics business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic Analgesics market......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs